0000899243-20-022197.txt : 20200812 0000899243-20-022197.hdr.sgml : 20200812 20200812210058 ACCESSION NUMBER: 0000899243-20-022197 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200810 FILED AS OF DATE: 20200812 DATE AS OF CHANGE: 20200812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kusserow Paul B. K. CENTRAL INDEX KEY: 0001456688 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24260 FILM NUMBER: 201096839 MAIL ADDRESS: STREET 1: 780 SAN YSIDRO ROAD CITY: SANTA BARBARA STATE: CA ZIP: 93108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 3854 AMERICAN WAY STREET 2: SUITE A CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-10 0 0000896262 AMEDISYS INC AMED 0001456688 Kusserow Paul B. K. 3854 AMERICAN WAY, SUITE A BATON ROUGE LA 70816 1 1 0 0 See Remarks Common Stock 2020-08-10 4 M 0 250000 26.65 A 299092 D Common Stock 2020-08-10 4 M 0 250000 26.78 A 549092 D Common Stock 2020-08-10 4 F 0 231683 231.92 D 317409 D Common Stock 101404 I By Trust Common Stock 621 I Through 401(k) Plan Stock Option (right to buy) 26.65 2020-08-10 4 M 0 250000 0.00 D 2015-12-16 2024-12-16 Common Stock 250000 0 D Stock Option (right to buy) 26.78 2020-08-10 4 M 0 250000 0.00 D 2025-03-31 Common Stock 250000 0 D The information in this report is based on a plan statement dated as of June 30, 2020. The stock option vested in four equal annual installments on each of December 16, 2015, December 16, 2016, December 16, 2017 and December 16, 2018. On March 31, 2015, the reporting person was granted an option to purchase 250,000 shares of common stock, which vested based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ended December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2015, 2016, 2017 and 2018 were met, resulting in vesting of the option as to all 250,000 shares. CEO, President and Chairman of the Board /s/ Jennifer R. Guckert, pursuant to a power of attorney 2020-08-12